Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery.
Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery.
复制标题
DOI:
10.1097/sla.0b013e3182519ccf
复制
发表时间:
2012-06
影响因子:
9
通讯作者:
Kheterpal S
中科院分区:
文献类型:
--
作者:
Pannucci CJ;Shanks A;Moote MJ;Bahl V;Cederna PS;Naughton NN;Wakefield TW;Henke PK;Campbell DA;Kheterpal S
To identify independent predictors of 30-day VTE events requiring treatment after outpatient surgery. An increasing proportion of surgical procedures are performed in the outpatient setting. The incidence of venous thromboembolism (VTE) requiring treatment after outpatient surgery is unknown. Prospective observational cohort study using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2005–2009. Adult patients who had outpatient surgery or surgery with subsequent 23-hour observation were included. The main outcome measure was 30-day VTE requiring treatment. Patients were randomly assigned to derivation (N=173,501) or validation (N=85,730) cohorts. Logistic regression examined independent risk factors for 30-day VTE. A weighted risk index was created and applied to the validation cohort. Stratified analyses examined 30-day VTE by risk level. 30-day incidence of VTE for the overall cohort was 0.15%. Independent risk factors included current pregnancy (adjusted odds ratio (OR) 7.80, p=0.044), active cancer (OR 3.66, p=0.005), age 41–59 (OR 1.72, p=0.008), age ≥60 (OR 2.48, p<0.001), body mass index ≥40 (OR 1.81, p=0.015), operative time ≥120 minutes (OR 1.69, p=0.027), arthroscopic surgery (OR 5.16, p<0.001), sapheno-femoral junction surgery (OR 13.20, p<0.001), and venous surgery not involving the great saphenous vein (OR 15.61, p<0.001). The weighted risk index identified a 20-fold variation in 30-day VTE between low (0.06%) and highest risk (1.18%) patients. 30-day VTE risk after outpatient surgery can be quantified using a weighted risk index. The risk index identifies a high-risk subgroup of patients with 30-day VTE rates of 1.18%.